Is DexCom, Inc. (DXCM) a Buy, Sell, or Hold?
NASDAQ : DXCM
DexCom, Inc. — Analyst Ratings
$83.45 USD
$8.91 (11.95%)
- Volume
- 11.98M
- Average Volume
- 5.71M
- Market Capitalization
- $31.49B
- P/E Ratio
- 32.22
- Dividend Yield
- 0.00%
- Price Target
- $91.50
- Year High
- $84.70
- Year Low
- $54.11
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.73
Analyst Consensus Summary
Consensus Rating
Neutral
52 Analysts
Rating Score
3/5
Recommendation Strength
Upside/Downside
-8.8%
vs Current Price
Price Target
$91.50
Average TargetPrice Target Range
Lowest Target
$64.00
30.4% UPSIDE
Average Target
$91.50
Median Estimate
Highest Target
$105.00
-20.5% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 52
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 1 | 41 | 8 | 2 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Raymond James | Jayson Bedford | $94 | $82.66 | 2026-07-31 08:29 AM | 13.7% |
| Piper Sandler | Matt O'Brien | $95 | $74.54 | 2026-07-31 07:30 AM | 27.4% |
| BTIG | Marie Thibault | $90 | $74.54 | 2026-07-31 05:26 AM | 20.7% |
| Truist Financial | Richard Newitter | $93 | $74.54 | 2026-07-31 05:04 AM | 24.8% |
| Stifel Nicolaus | Jonathan Block | $95 | $74.54 | 2026-07-31 05:03 AM | 27.4% |
| Piper Sandler | Matt O'Brien | $88 | $75.37 | 2026-06-15 06:37 AM | 16.8% |